These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibody-mediated rejection: a single center experience at Tokyo Women's Medical University. Tanabe K; Ishida H; Omoto K; Shimizu T; Shirakawa H Clin Transpl; 2006; ():363-9. PubMed ID: 18365390 [TBL] [Abstract][Full Text] [Related]
5. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction. Muro M; Llorente S; Gónzalez-Soriano MJ; Minguela A; Gimeno L; Alvarez-López MR Clin Transpl; 2006; ():379-83. PubMed ID: 18365392 [TBL] [Abstract][Full Text] [Related]
6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants. Fryer JP; Benedetti E; Perry EH; Matas AJ Transplantation; 1994 Sep; 58(6):723-5. PubMed ID: 7940694 [No Abstract] [Full Text] [Related]
8. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487 [TBL] [Abstract][Full Text] [Related]
9. Differential outcomes in 3 types of acute antibody-mediated rejection. Rafiq MA; de Boccardo G; Schröppel B; Bromberg JS; Sehgal V; Dinavahi R; Murphy B; Akalin E Clin Transplant; 2009; 23(6):951-7. PubMed ID: 19624692 [TBL] [Abstract][Full Text] [Related]
10. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Mizutani K; Terasaki PI; Shih RN; Pei R; Ozawa M; Lee J Hum Immunol; 2006 Mar; 67(3):223-9. PubMed ID: 16698446 [TBL] [Abstract][Full Text] [Related]
11. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients. Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965 [TBL] [Abstract][Full Text] [Related]
12. A new role for the virtual crossmatch in kidney allograft reuse. Bryan CF; Abdulkarim B; Forster J; Nelson PW; Diederich D; Murillo D; Markham L Transplantation; 2010 Mar; 89(6):764-5. PubMed ID: 20308864 [No Abstract] [Full Text] [Related]
14. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960 [TBL] [Abstract][Full Text] [Related]
15. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation. Li X; Ishida H; Yamaguchi Y; Tanabe K Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618 [TBL] [Abstract][Full Text] [Related]
16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
17. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data. Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA Clin Transpl; 2006; ():349-61. PubMed ID: 18365389 [TBL] [Abstract][Full Text] [Related]
18. Allosensitization to HLA and MICA is an important measure of renal graft outcome. Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK Clin Transpl; 2007; ():211-7. PubMed ID: 18637472 [TBL] [Abstract][Full Text] [Related]